✦ LIBER ✦

A prospective clinical trial evaluating the safety and efficacy of the combination of rituximab and plerixafor as a mobilization regimen for patients with lymphoma

✍ Scribed by Jonathan L. Kaufman; Christopher R. Flowers; Karen D. Rados; Gary B. Calandra; Julie M. Vose; L. Becker Hewes; Sagar Lonial; Amelia A. Langston; H. Jean Khoury; Mary Jo Lechowicz; Edmund K. Waller

Book ID: 114754402
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 144 KB
Volume: 53
Category: Article
ISSN: 0372-1248
DOI: 10.1111/j.1537-2995.2012.03719.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and preliminary efficacy of pleri

Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization

✍ Dugan, M J; Maziarz, R T; Bensinger, W I; Nademanee, A; Liesveld, J; Badel, K; D 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 237 KB

The Efficacy And Safety Of VP-16 And G-C

The Efficacy And Safety Of VP-16 And G-CSF As A Mobilization Regimen Prior To Autologous Stem Cell Transplantation (ASCT) For Patients (PTS) With Multiple Myeloma (MM) And Lymphoma

✍ J.S. Whitley; W.A. Wood; D.T. Moore; A. Sharf; R. Irons; K.V. Rao; J.S. Serody; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Safety and Efficacy of Combination Thera

Safety and Efficacy of Combination Therapy with Fludarabine, Mitoxantrone, and Rituximab Followed by Yttrium-90 Ibritumomab Tiuxetan and Maintenance Rituximab as Front-Line Therapy for Patients With Follicular or Marginal Zone Lymphoma

✍ Reem Karmali; Mohamad Kassar; Parameswaran Venugopal; Jamile M. Shammo; Henry C. 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 397 KB

NCI-Sponsored Trial for the Evaluation o

NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy of FLT as a Marker of Proliferation in Patients with Recurrent Gliomas: Safety Studies

✍ Alexander M. Spence; Mark Muzi; Jeanne M. Link; John M. Hoffman; Janet F. Eary; 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 364 KB

Evaluation of the safety of rituximab in

Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: Results from a randomized controlled trial

✍ Maria W. Greenwald; William J. Shergy; Jeffrey L. Kaine; Marianne T. Sweetser; K 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 3 views

Safety and efficacy of the M2A patency c

Safety and efficacy of the M2A patency capsule for diagnosis of critical intestinal patency: Results of a prospective clinical trial

✍ Rupa Banerjee; Prem Bhargav; Praveen Reddy; Rajesh Gupta; Sandeep Lakhtakia; Man 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB